C6orf222
- Known as:
- C6orf222
- Catalog number:
- 003235A
- Product Quantity:
- 250ul
- Category:
- -
- Supplier:
- ABM
- Gene target:
- C6orf222
Ask about this productRelated genes to: C6orf222
- Gene:
- C6orf222 NIH gene
- Name:
- chromosome 6 open reading frame 222
- Previous symbol:
- -
- Synonyms:
- DKFZp779B1540
- Chromosome:
- 6p21.31
- Locus Type:
- gene with protein product
- Date approved:
- 2007-12-18
- Date modifiied:
- 2016-11-22
Related products to: C6orf222
Related articles to: C6orf222
- Gastric cancer (GC) is one of the most common causes of cancer-related death. Drug resistance in chemotherapy often occurs in patients with GC, leading to tumor recurrence and poor survival. DNA methylation is closely related to the development of cancer. - Source: PubMed
Publication date: 2023/09/12
Li YeMo NingYang DongLin QiuLuHuang WenFengWang Rensheng - Although the treatment paradigm for hepatocellular carcinoma (HCC) has recently shifted in favour of checkpoint inhibitor (CPI)-based treatment options, the tyrosine kinase inhibitors (TKI) currently approved for the treatment of HCC are expected to remain the cornerstone of HCC treatment alone or in combination with CPIs. Despite considerable research efforts, no biomarker capable of predicting the response to specific TKIs has been validated. Thus, personalized approaches to HCC may aid in determining optimal treatment lines for 2nd and 3rd lines. To identify new biomarkers, we examined differential sensitivity and investigated potential transcriptomic predictors. - Source: PubMed
Publication date: 2022/07/09
Sagmeister PaulaDaza JimmyOfner AndreaZiesch AndreasYe LiangtaoBen Khaled NajibEbert MatthiasMayerle JuliaTeufel AndreasDe Toni Enrico NMunker Stefan